UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

Breast cancer research : BCR, 2016-03, Vol.18 (1), p.33-33, Article 33

2016

Volltextzugriff (PDF)

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

Nature communications, 2020-11, Vol.11 (1), p.5679-5679, Article 5679

2020

Volltextzugriff (PDF)

Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor

Oncogene, 2021-03, Vol.40 (12), p.2323-2334

2021

Volltextzugriff (PDF)

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Clinical cancer research, 2022-07, Vol.28 (13), p.2807-2817

2022

Volltextzugriff (PDF)

Association between socioeconomic factors at diagnosis and survival in breast cancer: A population‐based study

Cancer medicine (Malden, MA), 2020-03, Vol.9 (5), p.1922-1936

2020

Volltextzugriff (PDF)

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

Clinical cancer research, 2016-10, Vol.22 (19), p.4859-4869

2016

Volltextzugriff (PDF)

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial

Cancer, 2019-07, Vol.125 (13), p.2185-2193

2019

Volltextzugriff (PDF)

MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer

Clinical cancer research, 2013-03, Vol.19 (6), p.1389-1399

2013

Volltextzugriff (PDF)

No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma

Journal of surgical oncology, 2018-11, Vol.118 (6), p.928-935

2018

Volltextzugriff (PDF)

The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation

Science advances, 2019-03, Vol.5 (3), p.eaat9820-eaat9820

2019

Volltextzugriff (PDF)

Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations

Breast cancer research and treatment, 2021, Vol.185 (2), p.371-380

2021

Volltextzugriff (PDF)

Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer

Molecular therapy. Oncolytics, 2022-03, Vol.24, p.624-635

2022

Volltextzugriff (PDF)

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer

Breast cancer research : BCR, 2007-01, Vol.9 (6), p.R76-R76, Article R76

2007

Volltextzugriff (PDF)

The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer

Breast cancer research and treatment, 2012-02, Vol.131 (3), p.837-848

2012

Volltextzugriff (PDF)

Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial

Therapeutic advances in medical oncology, 2024-01, Vol.16, p.17588359231225032-17588359231225032

2024

Volltextzugriff (PDF)

Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer

Journal for immunotherapy of cancer, 2021-10, Vol.9 (10), p.e003371

2021

Volltextzugriff (PDF)

Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry

Proteomics (Weinheim), 2006-06, Vol.6 (11), p.3352-3368

2006

Volltextzugriff (PDF)

Calcifications in triple-negative breast cancer: Molecular features and treatment strategies

NPJ breast cancer, 2023-04, Vol.9 (1), p.26-26, Article 26

2023

Volltextzugriff (PDF)

Outcome of Pure Mucinous Breast Carcinoma Compared to Infiltrating Ductal Carcinoma: A Population-based Study from China

Annals of surgical oncology, 2012-09, Vol.19 (9), p.3019-3027

2012

Volltextzugriff (PDF)

Correction to: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer

Breast cancer research : BCR, 2018-07, Vol.20 (1), p.63-63, Article 63

2018

Volltextzugriff (PDF)

Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities

Cell discovery, 2023-12, Vol.9 (1), p.125-125, Article 125

2023

Volltextzugriff (PDF)

PA-MSHA inhibits proliferation and induces apoptosis through the up-regulation and activation of caspases in the human breast cancer cell lines

Journal of cellular biochemistry, 2009-09, Vol.108 (1), p.195-206

2009

Volltextzugriff (PDF)

Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial

The Lancet regional health. Western Pacific, 2021-06, Vol.11, p.100158-100158, Article 100158

2021

Volltextzugriff (PDF)

PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer

Cancer research (Chicago, Ill.), 2021-11, Vol.81 (21), p.5491-5505

2021

Volltextzugriff (PDF)

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial

JAMA oncology, 2020-09, Vol.6 (9), p.1390

2020

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(104)

Publikationsform

Artikel
(114)

Sprache

Englisch
(81)
Chinesisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Association between socioeconomic factors at diagnosis and survival in breast cancer: A population‐based study

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial

MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer

No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma

The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation

Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations

Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer

The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer

Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial

Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer

Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry

Calcifications in triple-negative breast cancer: Molecular features and treatment strategies

Outcome of Pure Mucinous Breast Carcinoma Compared to Infiltrating Ductal Carcinoma: A Population-based Study from China

Correction to: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer

Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities

PA-MSHA inhibits proliferation and induces apoptosis through the up-regulation and activation of caspases in the human breast cancer cell lines

Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial

PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial

Aktive Filter

Suchergebnisse filtern